Green tea epigallocatechin-3-gallate (EGCG) reduces β-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice
Abstract
We previously reported that intraperitoneal (i.p.) injection (20 mg/kg) of (-)-epigallocatechin-3-gallate (EGCG), the main polyphenolic constituent of green tea, decreased beta-amyloid (Abeta) levels and plaques via promotion of the non-amyloidogenic alpha-secretase proteolytic pathway in "Swedish" mutant amyloid precursor protein overexpressing (APPsw, Tg) mice. Here, we find that EGCG administered orally in drinking water (50 mg/kg) similarly reduces Abeta deposition in these mice. Following a six month treatment of an 8 month old cohort, immunohistochemical analysis of coronal sections reveals that plaque burdens were reduced in the cingulate cortex, hippocampus, and entorhinal cortex by 54%, 43%, and 51%, respectively. Congo red plaque burdens were decreased in the cingulate cortex, hippocampus, and entorhinal cortex by 53%, 53%, and 58%, respectively as well. ELISA of brain homogenates of the treatment Tg mice revealed consistent reductions in both Abeta1-40 and 1-42 soluble and insoluble forms. In the present study we also investigated the effect EGCG administration had on tau pathology and cognition in Tg mice. Both i.p. and orally-treated Tg animals were found to have modulated tau profiles, with markedly suppressed sarkosyl-soluble phosphorylated tau isoforms. Radial arm water maze (RAWM) testing for working memory indicated that EGCG provided cognitive benefit to Tg mice with both i.p. and oral administration, although i.p.-treated animals showed a more pronounced benefit because of the greater impairment of their Tg controls at the time of testing. Taken together, these data further the notion of EGCG dietary supplementation as a potentially safe and effective prophylaxis for Alzheimer's disease.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
BACE performs proteolysis by generating soluble APPβ and CTFβ; CTFβ undergoes γ-secretase proteolysis to generate toxic Aβ neuropeptides with 40-43 amino acids, finally causing the amyloid plaques characteristic of Alzheimer's disease.
“This protein known as the BACE performs proteolysis by generating a soluble fragment in the extracellular space known as “soluble APPβ” and an additional fragment bound to the plasma membrane, CTFβ peptide that undergoes proteolysis yet again by γ-secretase to generate toxic neuropeptides Aβ with 40–43 amino acids, finally causing the amyloid plaques characteristic of AD [165,166,167].”
From Multi-Target Mechanisms of Phytochemicals in Alzheimer’s Disease: Effects on Oxidative Stress, Neuroinflammation and Protein Aggregation (2022) · cites this paper as [166]
Cites
Correlative Memory Deficits, Aβ Elevation, and Amyloid Plaques in Transgenic Mice
Hsiao, K., Chapman, P., Nilsen, S., Eckman, C., Harigaya, Y., Younkin, S., Yang, F., & Cole, G. (1996) · Science · doi:10.1126/science.274.5284.99 · Cited by 4,210 · see citing works
Vassar, R., Bennett, B. D., Babu-Khan, S., Kahn, S., Mendiaz, E. A., Denis, P., Teplow, D. B., Ross, S., Amarante, P., Loeloff, R., et al. (1999) · Science · doi:10.1126/science.286.5440.735 · Cited by 3,876 · see citing works
Yang, F., Lim, G. P., Begum, A. N., Ubeda, O. J., Simmons, M. R., Ambegaokar, S. S., Chen, P. P., Kayed, R., Glabe, C. G., Frautschy, S. A., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m404751200 · Cited by 2,336 · see citing works
Deficiency of presenilin-1 inhibits the normal cleavage of amyloid precursor protein
De Strooper, B., Saftig, P., Craessaerts, K., Vanderstichele, H., Guhde, G., Annaert, W., Von Figura, K., & Van Leuven, F. (1998) · Nature · doi:10.1038/34910 · Cited by 1,818 · see citing works
Microtubule-associated protein tau. A component of Alzheimer paired helical filaments.
Grundke, I., Iqbal, K., Quinlan, M., Tung, Y. C., Zaidi, M. S., & Wisniewski, H. M. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)38495-8 · Cited by 1,780 · see citing works
Membrane-anchored aspartyl protease with Alzheimer's disease β-secretase activity
Yan, R., Bienkowski, M. J., Shuck, M. E., Miao, H., Tory, M. C., Pauley, A. M., Brashler, J. R., Stratman, N. C., Mathews, W. R., Buhl, A. E., et al. (1999) · Nature · doi:10.1038/990107 · Cited by 1,438 · see citing works
Neurotoxicity induces cleavage of p35 to p25 by calpain
Lee, M.-S., Kwon, Y. T., Li, M., Peng, J., Friedlander, R. M., & Tsai, L. (2000) · Nature · doi:10.1038/35012636 · Cited by 1,057 · see citing works
Alonso, A. D. C., Zaidi, T., Novák, M., Grundke, I., & Iqbal, K. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.121119298 · Cited by 968 · see citing works
Resveratrol Promotes Clearance of Alzheimer's Disease Amyloid-β Peptides
Marambaud, P., Zhao, H., & Davies, P. J. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m508246200 · Cited by 750 · see citing works
Greenberg, S. G., & Davies, P. J. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.15.5827 · Cited by 732 · see citing works
Tau protein and the neurofibrillary pathology of Alzheimer's disease
Goedert, M. (1993) · Trends in Neurosciences · doi:10.1016/0166-2236(93)90078-z · Cited by 718 · see citing works
Rezai-Zadeh, K., Shytle, D., Sun, N., Mori, T., Hou, H., Jeanniton, D., Ehrhart, J., Townsend, K., Zeng, J., Morgan, D., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1521-05.2005 · Cited by 713 · see citing works
Dickey, C. A., Kamal, A., Lundgren, K., Klosak, N., Bailey, R. M., Dunmore, J., Ash, P., Shoraka, S., Zlatkovic, J., Eckman, C. B., et al. (2007) · Journal of Clinical Investigation · doi:10.1172/jci29715 · Cited by 642 · see citing works
Johnson‐Wood, K., Lee, M., Motter, R. N., Hu, K., Gordon, G., Barbour, R., Khan, K., Gordon, M. N., Tan, H. T., Games, D., et al. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.4.1550 · Cited by 634 · see citing works
β-Amyloid fibrils induce tau phosphorylation and loss of microtubule binding
Busciglio, J., Lorenzo, A., Yeh, J., & Yankner, B. A. (1995) · Neuron · doi:10.1016/0896-6273(95)90232-5 · Cited by 595 · see citing works
Suganuma, M. (1998) · Carcinogenesis · doi:10.1093/carcin/19.10.1771 · Cited by 527 · see citing works
Neuron loss in APP transgenic mice
Calhoun, M. E., Wiederhold, K.-H., Abramowski, D., Phinney, A. L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., & Jucker, M. (1998) · Nature · doi:10.1038/27351 · Cited by 502 · see citing works
Arendash, G. W., Schleif, W. S., Rezai-Zadeh, K. P., Jackson, E. K., Zacharia, L. C., Cracchiolo, J. R., Shippy, D. C., & Tan, J. (2006) · Neuroscience · doi:10.1016/j.neuroscience.2006.07.021 · Cited by 461 · see citing works
Cellular mechanisms of β-amyloid production and secretion
Sinha, S., & Lieberburg, I. M. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.20.11049 · Cited by 438 · see citing works
Furukawa, K., Sopher, B. L., Rydel, R. E., Begley, J. G., Pham, D. G., Martin, G. M., Fox, M., & Mattson, M. P. (1996) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1996.67051882.x · Cited by 414 · see citing works
Levites, Y., Amit, T., Mandel, S. A., & Youdim, M. B. H. (2003) · The FASEB Journal · doi:10.1096/fj.02-0881fje · Cited by 372 · see citing works
Lambert, J. D., Lee, M., Lu, H., Meng, X., Hong, J. J. J., Seril, D. N., Yang, C. S., & Sturgill, M. G. (2003) · Journal of Nutrition · doi:10.1093/jn/133.12.4172 · Cited by 318 · see citing works
Steiner, H., Duff, K., Capell, A., Romig, H., Grim, M. G., Lincoln, S., Hardy, J., Yu, X., Picciano, M., Fechteler, K., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.40.28669 · Cited by 306 · see citing works
Golde, T. E., Eckman, C. B., & Younkin, S. G. (2000) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/s0925-4439(00)00043-0 · Cited by 300 · see citing works
Stein, T. D., Anders, N. J., DeCarli, C. S., Chan, S. L., Mattson, M. P., & Johnson, J. A. (2004) · Journal of Neuroscience · doi:10.1523/jneurosci.2211-04.2004 · Cited by 277 · see citing works
Lithium protects cultured neurons against β‐amyloid‐induced neurodegeneration
Alvarez, G., Muñoz-Montaño, J. R., Satrústegui, J., Ávila, J., Bogónez, E., & Díaz‐Nido, J. (1999) · FEBS Letters · doi:10.1016/s0014-5793(99)00685-7 · Cited by 270 · see citing works
The Role of APP Processing and Trafficking Pathways in the Formation of Amyloid β‐Proteina
Selkoe, D. J., Yamazaki, T., Citron, M., Podlisny, M. B., Koo, E. H., Teplow, D. B., & Haass, C. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34401.x · Cited by 246 · see citing works
Cellular signaling roles of TGFβ, TNFα and βAPP in brain injury responses and Alzheimer's disease
Mattson, M. P., Barger, S. W., Furukawa, K., Bruce‐Keller, A. J., Wyss‐Coray, T., Mark, R. J., & Mucke, L. (1997) · Brain Research Reviews · doi:10.1016/s0165-0173(96)00014-8 · Cited by 243 · see citing works
Behavioral characterization of the Tg2576 transgenic model of Alzheimer's disease through 19 months
King, D. L., & Arendash, G. W. (2002) · Physiology & Behavior · doi:10.1016/s0031-9384(02)00639-x · Cited by 242 · see citing works
Role of CD40 ligand in amyloidosis in transgenic Alzheimer's mice
Tan, J., Town, T., Crawford, F., Mori, T., DelleDonne, A., Crescentini, R., Obregon, D., Flavell, R. A., & Mullan, M. J. (2002) · Nature Neuroscience · doi:10.1038/nn968 · Cited by 217 · see citing works
Obregon, D. F., Rezai-Zadeh, K. P., Bai, Y., Sun, N., Hou, H., Ehrhart, J. C., Zeng, J., Mori, T., Arendash, G. W., Shytle, D., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m600617200 · Cited by 210 · see citing works
Wang, J.-Z., Wu, Q., Smith, A., Grundke, I., & Iqbal, K. (1998) · FEBS Letters · doi:10.1016/s0014-5793(98)01090-4 · Cited by 199 · see citing works
Advances in the Cellular and Molecular Biology of the Beta-Amyloid Protein in Alzheimer 's Disease
Sambamurti, K., Greig, N. H., & Lahiri, D. K. (2002) · NeuroMolecular Medicine · doi:10.1385/nmm:1:1:1 · Cited by 184 · see citing works
Palermo, C. M., Westlake, C. A., & Gasiewicz, T. A. (2005) · Biochemistry · doi:10.1021/bi047433p · Cited by 167 · see citing works
Green tea catechins prevent cognitive deficits caused by Aβ1–40 in rats
Haque, A. M., Hashimoto, M., Katakura, M., Hara, Y., & Shido, O. (2008) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2007.08.008 · Cited by 139 · see citing works
Funamoto, S., Morishima‐Kawashima, M., Tanimura, Y., Hirotani, N., Saido, T. C., & Ihara, Y. (2004) · Biochemistry · doi:10.1021/bi049399k · Cited by 131 · see citing works
Arendash, G. W., Gordon, M. N., Diamond, D. M., Austin, L. A., Hatcher-Martin, J. M., Jantzen, P. T., DiCarlo, G., Wilcock, D. M., & Morgan, D. (2001) · DNA and Cell Biology · doi:10.1089/10445490152717604 · Cited by 130 · see citing works
The Search for α-Secretase and its Potential as a Therapeutic Approach to Alzheimer's Disease
Hooper, N. M., & Turner, A. J. (2002) · Current Medicinal Chemistry · doi:10.2174/0929867023370121 · Cited by 127 · see citing works
Arendash, G. W., Lewis, J., Leighty, R. E., McGowan, E., Cracchiolo, J. R., Hutton, M., & Garcia, M. F. (2004) · Brain Research · doi:10.1016/j.brainres.2004.02.081 · Cited by 127 · see citing works
Self-citationPhosphorylated tau and the neurodegenerative foldopathies
Kosik, K. S., & Shimura, H. (2004) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2004.10.011 · Cited by 123 · see citing works
Tau Protein and the Neurofibrillary Pathology of Alzheimer's Disease
Goedert, M. (1996) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1996.tb34410.x · Cited by 115 · see citing works
Brion, J., Hanger, D. P., Couck, A. M., & Anderton, B. H. (1991) · Biochemical Journal · doi:10.1042/bj2790831 · Cited by 109 · see citing works
Mattson, M. P., Guo, Z. H., & Geiger, J. D. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0730532.x · Cited by 96 · see citing works
Lichtenthaler, S. F., & Haass, C. (2004) · Journal of Clinical Investigation · doi:10.1172/jci21746 · Cited by 88 · see citing works
Phosphorylation of Tau, Aβ-Formation, and Apoptosis After In Vivo Inhibition of PP-1 and PP-2A
Arendt, T., Holzer, M., Fruth, R., Brückner, M. K., & Gärtner, U. (1998) · Neurobiology of Aging · doi:10.1016/s0197-4580(98)00003-7 · Cited by 88 · see citing works
Closing in on the Amyloid Cascade
Doms, R. W., & Huse, J. T. (2000) · Molecular Neurobiology · doi:10.1385/mn:22:1-3:081 · Cited by 49 · see citing works
Leighty, R. E., Nilsson, L. N. G., Potter, H., Costa, D. A., Low, M. A., Bales, K. R., Paul, S. M., & Arendash, G. W. (2004) · Behavioural Brain Research · doi:10.1016/j.bbr.2003.11.004 · Cited by 47 · see citing works
Shin, R., Bramblett, G. T., Lee, V. M., & Trojanowski, J. Q. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.14.6825 · Cited by 45 · see citing works
Yamamoto, H., Yamauchi, E., Taniguchi, H., Ono, T., & Miyamoto, E. (2002) · Archives of Biochemistry and Biophysics · doi:10.1016/s0003-9861(02)00556-8 · Cited by 39 · see citing works
Secreted β-APP stimulates MAP kinase and phosphorylation of tau in neurons
Greenberg, S. M., & Kosik, K. S. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(94)00172-w · Cited by 28 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Buendía, I., Michalska, P., Navarro, E., Gameiro‐Ros, I., Egea, J., & Leon, R. M. (2015) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.11.003 · Cited by 683 · see citing works
Bioinorganic Chemistry of Alzheimer’s Disease
Kepp, K. P. (2012) · Chemical Reviews · doi:10.1021/cr300009x · Cited by 672 · see citing works
Kennedy, D. O., & Wightman, E. L. (2011) · Advances in Nutrition · doi:10.3945/an.110.000117 · Cited by 684 · see citing works
Savelieff, M. G., Nam, G., Kang, J., Lee, H. J., Lee, M., & Lim, M.-H. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00138 · Cited by 490 · see citing works
Therapeutic applications of compounds in the Magnolia family
Lee, Y., Lee, Y. M., Lee, C., Jung, J., Han, S., & Hong, J. T. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.01.010 · Cited by 490 · see citing works
Nutraceutical Antioxidants as Novel Neuroprotective Agents
Kelsey, N. A., Wilkins, H., & Linseman, D. A. (2010) · Molecules · doi:10.3390/molecules15117792 · Cited by 481 · see citing works
Prasanth, M. I., Sivamaruthi, B. S., Chaiyasut, C., & Tencomnao, T. (2019) · Nutrients · doi:10.3390/nu11020474 · Cited by 457 · see citing works
Williams, R. J., & Spencer, J. P. E. (2012) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2011.09.010 · Cited by 448 · see citing works
Sabogal-Guáqueta, A. M., Muñoz‐Manco, J. I., Ramírez‐Pineda, J. R., Lamprea, M. R., Osorio, E., & Cardona‐Gómez, G. P. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.01.027 · Cited by 453 · see citing works
Vauzour, D. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/914273 · Cited by 431 · see citing works
Naturally occurring phytochemicals for the prevention of Alzheimer’s disease
Kim, J., Lee, H. J., & Lee, K. W. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06562.x · Cited by 354 · see citing works
Ayaz, M., Sadiq, A., Junaid, M., Ullah, F., Ovais, M., Ullah, I., Ahmed, J., & Shahid, M. M. (2019) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2019.00155 · Cited by 348 · see citing works
Potential neuroprotective properties of epigallocatechin-3-gallate (EGCG)
Singh, N. A., Mandal, A. K. A., & Khan, Z. A. (2015) · Nutrition Journal · doi:10.1186/s12937-016-0179-4 · Cited by 319 · see citing works
Management of oxidative stress and other pathologies in Alzheimer’s disease
Simunkova, M., Alwasel, S. H., Alhazza, I. M., Jomova, K., Kollar, V., Rusko, M., & Valko, M. (2019) · Archives of Toxicology · doi:10.1007/s00204-019-02538-y · Cited by 303 · see citing works
Polyphenols from Food and Natural Products: Neuroprotection and Safety
Silva, R. F. M., & Pogačnik, L. (2020) · Antioxidants · doi:10.3390/antiox9010061 · Cited by 292 · see citing works
Marzia Perluigi, A., Domenico, F. D., & Butterfield, D. A. (2023) · Physiological Reviews · doi:10.1152/physrev.00030.2022 · Cited by 306 · see citing works
Meng, F., Abedini, A., Plesner, A., Verchere, C. B., & Raleigh, D. P. (2010) · Biochemistry · doi:10.1021/bi100939a · Cited by 282 · see citing works
Inhibition and disaggregation of α-synuclein oligomers by natural polyphenolic compounds
Caruana, M., Högen, T., Levin, J., Hillmer, A. S., Giese, A., & Vassallo, N. (2011) · FEBS Letters · doi:10.1016/j.febslet.2011.03.046 · Cited by 274 · see citing works
Caloric restriction mimetics: towards a molecular definition
Madeo, F., Pietrocola, F., Eisenberg, T., & Kroemer, G. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4391 · Cited by 264 · see citing works
Beneficial Effects of Green Tea Catechins on Neurodegenerative Diseases
Pervin, M., Unno, K., Ohishi, T., Tanabe, H., Miyoshi, N., & Nakamura, Y. (2018) · Molecules · doi:10.3390/molecules23061297 · Cited by 258 · see citing works
Potì, F., Santi, D., Spaggiari, G., Zimetti, F., & Zanotti, I. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020351 · Cited by 256 · see citing works
Weinreb, O., Amit, T., Mandel, S. A., & Youdim, M. B. H. (2009) · Genes & Nutrition · doi:10.1007/s12263-009-0143-4 · Cited by 244 · see citing works
Daglia, M., Lorenzo, A. D., Nabavi, S. F., Talas, Z., & Nabavi, S. F. (2014) · Current Pharmaceutical Biotechnology · doi:10.2174/138920101504140825120737 · Cited by 244 · see citing works
Phenolic compounds of green tea: Health benefits and technological application in food
Lorenzo, J. M., & Munekata, P. E. S. (2016) · Asian Pacific Journal of Tropical Biomedicine · doi:10.1016/j.apjtb.2016.06.010 · Cited by 239 · see citing works
Current and Emerging Drug Treatment Options for Alzheimerʼs Disease
Herrmann, N., Chau, S. A., Kircanski, I., & Lanctôt, K. L. (2011) · Drugs · doi:10.2165/11595870-000000000-00000 · Cited by 238 · see citing works
Neurotherapeutic applications of nanoparticles in Alzheimer’s disease
Sahni, J. K., Doggui, S., Ali, J., Baboota, S., Dao, L., & Ramassamy, C. (2011) · Journal of Controlled Release · doi:10.1016/j.jconrel.2010.11.033 · Cited by 219 · see citing works
Cheng, B., Gong, H., Xiao, H., Petersen, R. B., Zheng, L., & Huang, K. (2013) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2013.06.029 · Cited by 219 · see citing works
Nutrition and the Risk of Alzheimer's Disease
Hu, N., Yu, J., Tan, L., Wang, Y., Sun, L., & Tan, L. (2013) · BioMed Research International · doi:10.1155/2013/524820 · Cited by 212 · see citing works
Oxidative stress and Alzheimer’s disease: dietary polyphenols as potential therapeutic agents
Darvesh, A. S., Carroll, R. T., Bishayee, A., Geldenhuys, W. J., & der Schyf, C. J. V. (2010) · Expert Review of Neurotherapeutics · doi:10.1586/ern.10.42 · Cited by 203 · see citing works
Natural product-based amyloid inhibitors
Velander, P., Wu, L., Henderson, F. E., Zhang, S., Bevan, D. R., & Xu, B. (2017) · Biochemical Pharmacology · doi:10.1016/j.bcp.2017.04.004 · Cited by 203 · see citing works
Zhang, J., Zhou, X., Yu, Q., Yang, L., Sun, D., Zhou, Y., & Liu, J. (2014) · ACS Applied Materials & Interfaces · doi:10.1021/am501341u · Cited by 199 · see citing works
Lee, Y., Choi, D., Yun, Y., Han, S., Oh, K., & Hong, J. T. (2012) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2012.06.011 · Cited by 195 · see citing works
Kim, T. I., Lee, Y. K., Park, S. G., Choi, I. S., Ban, J. O., Park, H. K., Nam, S.-Y., Yun, Y. W., Han, S., Oh, K. W., et al. (2009) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2009.09.008 · Cited by 194 · see citing works
Guo, C., Wang, P., Zhong, M., Wang, T., Huang, X., Li, J., & Wang, Z. (2012) · Neurochemistry International · doi:10.1016/j.neuint.2012.12.005 · Cited by 190 · see citing works
Young, L. M., Cao, P., Raleigh, D. P., Ashcroft, A. E., & Radford, S. E. (2013) · Journal of the American Chemical Society · doi:10.1021/ja406831n · Cited by 190 · see citing works
Flavonoids as Therapeutic Compounds Targeting Key Proteins Involved in Alzheimer’s Disease
Baptista, F. I., Henriques, A. G., Silva, A. M. S., Wiltfang, J., & Silva, O. A. B. D. C. E. (2013) · ACS Chemical Neuroscience · doi:10.1021/cn400213r · Cited by 189 · see citing works
Dragicevic, N., Smith, A., Lin, X., Yuan, F., Copes, N., Delic, V., Tan, J., Cao, C., Shytle, R. D., & Bradshaw, P. C. (2011) · Journal of Alzheimer s Disease · doi:10.3233/jad-2011-101629 · Cited by 189 · see citing works
The Role of Phytochemicals in the Treatment and Prevention of Dementia
Howes, M. R., & Perry, E. K. (2011) · Drugs & Aging · doi:10.2165/11591310-000000000-00000 · Cited by 187 · see citing works
Schroeder, E. K., Kelsey, N. A., Doyle, J., Breed, E. R., Bouchard, R. J., Loucks, F. A., Harbison, R. A., & Linseman, D. A. (2008) · Antioxidants and Redox Signaling · doi:10.1089/ars.2008.2215 · Cited by 177 · see citing works
Biochemistry of Antioxidants: Mechanisms and Pharmaceutical Applications
Losada‐Barreiro, S., Bayındır, Z. S., Paiva‐Martins, F., & Bravo‐Díaz, C. (2022) · Biomedicines · doi:10.3390/biomedicines10123051 · Cited by 178 · see citing works
Biasibetti, R., Tramontina, A. C., Costa, A. P., Dutra, M. F., Quincozes‐Santos, A., Nardin, P., Bernardi, C. L., Wartchow, K. M., Lunardi, P. S., & Gonçalves, C. (2012) · Behavioural Brain Research · doi:10.1016/j.bbr.2012.08.039 · Cited by 177 · see citing works
Noguchi-Shinohara, M., Yuki, S., Dohmoto, C., Ikeda, Y., Samuraki, M., Iwasa, K., Yokogawa, M., Asai, K., Komai, K., Nakamura, H., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0096013 · Cited by 174 · see citing works
Protective role of epigallocatechin-3-gallate in health and disease: A perspective
Chowdhury, A., Sarkar, J., Chakraborti, T., Pramanik, P. K., & Chakraborti, S. (2016) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.12.013 · Cited by 164 · see citing works
Cascella, M., Bimonte, S., Muzio, M. R., Schiavone, V., & Cuomo, A. (2017) · Infectious Agents and Cancer · doi:10.1186/s13027-017-0145-6 · Cited by 167 · see citing works
Structural Properties of EGCG-Induced, Nontoxic Alzheimer's Disease Aβ Oligomers
del Amo, J. M. L., Fink, U., Dasari, M., Grelle, G., Wanker, E. E., Bieschke, J., & Reif, B. (2012) · Journal of Molecular Biology · doi:10.1016/j.jmb.2012.01.013 · Cited by 162 · see citing works
Acute neurocognitive effects of epigallocatechin gallate (EGCG)
Scholey, A. B., Downey, L. A., Ciorciari, J., Pipingas, A., Nolidin, K., Finn, M., Wines, M., Catchlove, S. J., Terrens, A., Barlow, E., et al. (2011) · Appetite · doi:10.1016/j.appet.2011.11.016 · Cited by 150 · see citing works
Diomede, L., Rigacci, S., Romeo, M., Stefani, M., & Salmona, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058893 · Cited by 146 · see citing works
Liu, F., Dong, X., He, L., Middelberg, A. P. J., & Sun, Y. P. (2011) · The Journal of Physical Chemistry B · doi:10.1021/jp202640b · Cited by 142 · see citing works
Natural polyphenols effects on protein aggregates in Alzheimer's and Parkinson's prion-like diseases
Bilan, A. R., Freyssin, A., Page, G., & Fauconneau, B. (2018) · Neural Regeneration Research · doi:10.4103/1673-5374.233432 · Cited by 141 · see citing works
Cognitive function and tea consumption in community dwelling older Chinese in Singapore
Feng, L., Gwee, X., Kua, E. H., & Ng, T. P. (2010) · The journal of nutrition health & aging · doi:10.1007/s12603-010-0095-9 · Cited by 139 · see citing works
Polyphenols and neuroprotection: therapeutic implications for cognitive decline
Caruso, G., Torrisi, S. A., Mogavero, M. P., Currenti, W., Castellano, S., Godos, J., Ferri, R., Galvano, F., Leggio, G. M., Grosso, G., et al. (2022) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2021.108013 · Cited by 140 · see citing works
Hudson, S. A., Ecroyd, H. W., Dehle, F. C., Musgrave, I., & Carver, J. A. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2009.07.031 · Cited by 138 · see citing works
Tewari, D., Stankiewicz, A. M., Mocan, A., Sah, A. N., Tzvetkov, N. T., Huminiecki, Ł., Horbańczuk, J. O., & Atanasov, A. G. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00003 · Cited by 136 · see citing works
Vauzour, D. (2013) · Journal of the Science of Food and Agriculture · doi:10.1002/jsfa.6473 · Cited by 136 · see citing works
Molecular Insight into the Therapeutic Promise of Flavonoids against Alzheimer’s Disease
Uddin, M. S., Kabir, M. T., Niaz, K., Jeandet, P., Clément, C., Mathew, B., Rauf, A., Rengasamy, K. R. R., Sobarzo‐Sánchez, E., Ashraf, G. M., et al. (2020) · Molecules · doi:10.3390/molecules25061267 · Cited by 134 · see citing works
Ansari, N., & Khodagholi, F. (2013) · Current Neuropharmacology · doi:10.2174/1570159x11311040005 · Cited by 131 · see citing works
Neurotheranostics as Personalized Medicines
Kevadiya, B. D., Ottemann, B. M., Thomas, M. B., Mukadam, I., Nigam, S., McMillan, J., Gorantla, S., Bronich, T. K., Edagwa, B., & Gendelman, H. E. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.10.011 · Cited by 124 · see citing works
Black Tea Theaflavins Inhibit Formation of Toxic Amyloid-β and α-Synuclein Fibrils
Grelle, G., Otto, A., Lorenz, M., Frank, R. F., Wanker, E. E., & Bieschke, J. (2011) · Biochemistry · doi:10.1021/bi2012383 · Cited by 130 · see citing works
Walker, J. M., Klakotskaia, D., Ajit, D., Weisman, G. A., Wood, W. G., Sun, G. Y., Serfözö, P. D., Simonyi, Á., & Schachtman, T. R. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-140981 · Cited by 128 · see citing works
Bioactive Polyphenols and Neuromodulation: Molecular Mechanisms in Neurodegeneration
Meo, F. D., Valentino, A., Petillo, O., Peluso, G., Filosa, S., & Crispi, S. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072564 · Cited by 127 · see citing works
Rifampicin is a candidate preventive medicine against amyloid-β and tau oligomers
Umeda, T., Ono, K., Sakai, A., Yamashita, M., Mizuguchi, M., Klein, W. L., Yamada, M., Mori, H., & Tomiyama, T. (2016) · Brain · doi:10.1093/brain/aww042 · Cited by 125 · see citing works
Sharifi-Rad, J., Rapposelli, S., Sestito, S., Herrera-Bravo, J., Arancibia-Diaz, A., Salazar, L. A., Yeskaliyeva, B., Beyatli, A., Leyva-Gómez, G., González-Contreras, C., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12091515 · Cited by 125 · see citing works
Jayasena, T., Poljak, A., Smythe, G. A., Braidy, N., Münch, G. W., & Sachdev, P. S. (2013) · Ageing Research Reviews · doi:10.1016/j.arr.2013.06.003 · Cited by 120 · see citing works
Effects of Polyphenols on Brain Ageing and Alzheimer’s Disease: Focus on Mitochondria
Schaffer, S., Asseburg, H., Kuntz, S., Muller, W. E., & Eckert, G. P. (2012) · Molecular Neurobiology · doi:10.1007/s12035-012-8282-9 · Cited by 123 · see citing works
Kumar, P., & Kumar, A. (2009) · Food and Chemical Toxicology · doi:10.1016/j.fct.2009.07.011 · Cited by 118 · see citing works
Liu, M., Chen, F., Sha, L., Wang, S., Lin, T., Yao, L., He, M., Yao, Z., Liu, H., Zhu, Z., et al. (2013) · Molecular Neurobiology · doi:10.1007/s12035-013-8608-2 · Cited by 117 · see citing works
Wightman, E. L., Haskell‐Ramsay, C. F., Forster, J. S., Veasey, R. C., & Kennedy, D. O. (2012) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1263 · Cited by 116 · see citing works
Flanagan, E. C., Müller, M. M., Hornberger, M., & Vauzour, D. (2018) · Current Nutrition Reports · doi:10.1007/s13668-018-0226-1 · Cited by 115 · see citing works
Gonçalves, P. B., Sodero, A. C. R., & Cordeiro, Y. (2021) · Biomolecules · doi:10.3390/biom11050767 · Cited by 115 · see citing works
The immunology of traumatic brain injury: a prime target for Alzheimer’s disease prevention
Giunta, B., Obregon, D., Velisetty, R., Sanberg, P. R., Borlongan, C. V., & Tan, J. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-185 · Cited by 112 · see citing works
Self-citationCounteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease
Sharma, V., Kaur, A., & Singh, T. G. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110373 · Cited by 114 · see citing works
Pleiotropic Protective Effects of Phytochemicals in Alzheimer's Disease
Davinelli, S., Sapere, N., Zella, D., Bracale, R., Intrieri, M., & Scapagnini, G. (2012) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2012/386527 · Cited by 111 · see citing works
Green Tea Polyphenol Epigallocatechin-Gallate in Amyloid Aggregation and Neurodegenerative Diseases
Fernandes, L., Cardim-Pires, T. R., Foguel, D., & Palhano, F. L. (2021) · Frontiers in Neuroscience · doi:10.3389/fnins.2021.718188 · Cited by 111 · see citing works
Li, J., Li, Y., Wang, X., Liu, J., Wang, Y., Zhou, Y., & Ho, W. (2012) · Journal of Neuroinflammation · doi:10.1186/1742-2094-9-161 · Cited by 106 · see citing works
Kroes-Nijboer, A., Venema, P., & van der Linden, E. (2011) · Food & Function · doi:10.1039/c1fo10163c · Cited by 105 · see citing works
Wang, Y., Li, M., Xu, X., Song, M., Tao, H., & Bai, Y. (2012) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201200035 · Cited by 105 · see citing works
Neuronal and Vascular Oxidative Stress in Alzheimers Disease
Massaad, C. A. (2011) · Current Neuropharmacology · doi:10.2174/157015911798376244 · Cited by 103 · see citing works
Ahmed, M. E., Khan, M. M., Javed, H., Vaibhav, K., Khan, A., Tabassum, R., Ashafaq, M., Islam, F., Safhi, M. M., & Islam, F. (2013) · Neurochemistry International · doi:10.1016/j.neuint.2013.02.006 · Cited by 103 · see citing works
Guerrero‐Munoz, M. J., Castillo‐Carranza, D. L., & Kayed, R. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.12.023 · Cited by 103 · see citing works
Ortiz-López, L. I., Márquez‐Valadez, B., Gómez‐Sánchez, A., Silva‐Lucero, M., Torres-Pérez, M. O., Tellez-Ballesteros, R. I., Ichwan, M., Meraz‐Ríos, M. A., Kempermann, G., & Ramírez-Rodríguez, G. B. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.02.040 · Cited by 103 · see citing works
Genistein: A Dual Inhibitor of Both Amyloid β and Human Islet Amylin Peptides
Ren, B., Liu, Y., Zhang, Y., Cai, Y., Gong, X., Chang, Y., Xu, L., & Zheng, J. (2018) · ACS Chemical Neuroscience · doi:10.1021/acschemneuro.8b00039 · Cited by 102 · see citing works
Polyphenols Modulate Alzheimer’s Amyloid Beta Aggregation in a Structure-Dependent Manner
Phan, H. T. T., Samarat, K., Takamura, Y., Oussou-Azo, A. F., Nakazono, Y., & Vestergaard, M. C. M. (2019) · Nutrients · doi:10.3390/nu11040756 · Cited by 103 · see citing works
Wang, S., Liu, F., Dong, X., & Sun, Y. P. (2010) · The Journal of Physical Chemistry B · doi:10.1021/jp1001435 · Cited by 98 · see citing works
Schimidt, H. L., Garcia, A., Martins, A., Mello‐Carpes, P. B., & Carpes, F. P. (2017) · Food Research International · doi:10.1016/j.foodres.2017.07.026 · Cited by 97 · see citing works
Chen, R., Wang, J., Zhang, X., Ren, J. M., & Zeng, C. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2010.12.033 · Cited by 96 · see citing works
Wu, K., Hsieh, M., Wu, C., Wood, W. G., & Chen, Y.-F. (2012) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2012/163106 · Cited by 96 · see citing works
Melrose, J. (2023) · Antioxidants · doi:10.3390/antiox12030663 · Cited by 95 · see citing works
Nanotechnology for Alzheimer’s disease detection and treatment
Nazem, A., & Mansoori, G. A. (2011) · Insciences Journal · doi:10.5640/insc.0104169 · Cited by 93 · see citing works
Baluchnejadmojarad, T., & Roghani, M. (2011) · Behavioural Brain Research · doi:10.1016/j.bbr.2011.06.007 · Cited by 92 · see citing works
Drobny, A., Huarcaya, S. P., Dobert, J., Kluge, A., Bunk, J., Schlothauer, T., & Zunke, F. (2022) · Biochimica et biophysica acta. Molecular cell research · doi:10.1016/j.bbamcr.2022.119243 · Cited by 86 · see citing works
Cognitive Enhancers (Nootropics). Part 1: Drugs Interacting with Receptors
Froestl, W., Muhs, A., & Pfeifer, A. (2012) · Journal of Alzheimer s Disease · doi:10.3233/jad-2012-121186 · Cited by 91 · see citing works
Fatima, M. T., Bhat, A. A., Nisar, S., Fakhro, K. A., & Akil, A. A. (2022) · Heliyon · doi:10.1016/j.heliyon.2022.e12698 · Cited by 90 · see citing works
Association of Tea Consumption with Risk of Alzheimer’s Disease and Anti-Beta-Amyloid Effects of Tea
Polito, C. A., Cai, Z., Shi, Y., Li, X.-M., Yang, R., Shi, M., Li, Q., Ma, S., Xiang, L., Wang, K., et al. (2018) · Nutrients · doi:10.3390/nu10050655 · Cited by 89 · see citing works
Inoue, H., Akiyama, S., Maeda‐Yamamoto, M., Nesumi, A., Tanaka, T., & Murakami, A. (2011) · Cell Stress and Chaperones · doi:10.1007/s12192-011-0280-8 · Cited by 88 · see citing works
Tau-induced neurodegeneration: mechanisms and targets
Beharry, C., Cohen, L. S., Di, J., Ibrahim, K., Briffa-Mirabella, S., & Alonso, A. D. C. (2014) · Neuroscience Bulletin · doi:10.1007/s12264-013-1414-z · Cited by 88 · see citing works
Dietary (−)-epicatechin as a potent inhibitor of βγ-secretase amyloid precursor protein processing
Cox, C. J., Choudhry, F., Peacey, E., Perkinton, M. S., Richardson, J. C., Howlett, D. R., Lichtenthaler, S. F., Francis, P. T., & Williams, R. J. (2014) · Neurobiology of Aging · doi:10.1016/j.neurobiolaging.2014.07.032 · Cited by 87 · see citing works
Dragicevic, N., Delic, V., Cao, C., Copes, N., Lin, X., Mamcarz, M., Wang, L., Arendash, G. W., & Bradshaw, P. C. (2012) · Neuropharmacology · doi:10.1016/j.neuropharm.2012.08.018 · Cited by 85 · see citing works
Lee, M., Kim, H., Lee, S.-H., Kim, Y. J., Asamenew, G., Choi, J., Lee, J. W., Jung, H.-A., Yoo, S. M., & Kim, J.-B. (2018) · European Food Research and Technology · doi:10.1007/s00217-018-3201-6 · Cited by 84 · see citing works
Natural Compounds May Open New Routes to Treatment of Amyloid Diseases
Bieschke, J. (2013) · Neurotherapeutics · doi:10.1007/s13311-013-0192-7 · Cited by 84 · see citing works
Sommer, A. P., Bieschke, J., Friedrich, R. P., Zhu, D., Wanker, E. E., Fecht, H. ‐., Mereles, D., & HUNSTEIN, W. (2011) · Photomedicine and Laser Surgery · doi:10.1089/pho.2011.3073 · Cited by 83 · see citing works
- Authors
- Rezai-Zadeh, K., Arendash, G. W., Hou, H., Fernandez, F., Jensen, M., Runfeldt, M., Shytle, R. D., & Tan, J.
- Affiliations
- University of South Florida (US)
- USF Health Byrd Alzheimer's Institute (US)
- Corresponding author
- Tan, Jun
- Venue
- Brain Research
- Publisher
- Elsevier BV
- Published
- 2008-06
- Volume
- 1214
- Pages
- 177-187
- ISSN
- 0006-8993 (ISSN-L)
- OpenAlex
- W2052380265
- Cited by
- 459
- References
- 50
- Citations by year
- 2026: 14 · 2025: 28 · 2024: 17 · 2023: 26 · 2022: 27 · 2021: 30 · 2020: 37 · 2019: 20 · 2018: 28 · 2017: 31 · 2016: 20 · 2015: 27 · 2014: 27 · 2013: 33 · 2012: 32
- FWCI
- 13.81
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Brain Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute on Aging (AG04418, P01AG004418, R21AG031037, P50AG025711, AG025711, AG031037)
- Topics
- Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Pathology and Forensic Medicine › Tea Polyphenols and Effects
- Health Sciences › Medicine › Complementary and alternative medicine › Medicinal Plants and Neuroprotection
- Keywords
- epigallocatechin gallate, green tea polyphenols, Alzheimer's disease, amyloid plaques, tau phosphorylation, oral administration, working memory, cognitive impairment, dietary supplementation, neuroprotection
- MeSH terms
- Alzheimer Disease, Analysis of Variance, Animals, Catechin, Cognition Disorders, Disease Models, Animal, Enzyme-Linked Immunosorbent Assay, Mice, Transgenic, Mutation, Phosphorylation, Amyloid beta-Peptides, Amyloid beta-Protein Precursor, tau Proteins, Neuroprotective Agents, Maze Learning, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review